Choices for Increased Mobility Act of 2025
- Sponsor
- Rep. John Joyce (R-PA-13) (R)
- Introduced
- 2025-02-27
- Latest action
- Placed on the Union Calendar, Calendar No. 656. (2026-07-18)
No recorded vote yet
This bill has not received a recorded floor vote. Most bills never do — they are introduced, referred to committee, and go no further. If it reaches a vote, every member's position will appear here.
AI-generated summary. Written by a language model from the bill's official title and description — not by a person, and not a substitute for the bill text. Vote counts, sponsors and dates above come from the official record, not from this summary. How we build this.
HR 1703, the Choices for Increased Mobility Act of 2025, would expand access to motorized mobility devices for Medicare beneficiaries by allowing beneficiaries to choose between receiving a device directly from Medicare or receiving a cash allowance to purchase one independently. The bill aims to increase beneficiary choice and competition in the mobility device market, potentially lowering costs and improving access to equipment. The legislation would directly affect Medicare recipients who need mobility aids such as wheelchairs and scooters, as well as mobility device suppliers and manufacturers.
The bill was introduced amid ongoing debate over Medicare's medical equipment benefit policies and concerns that current supply arrangements may limit patient choice or result in higher costs. The unanimous committee vote of 45-0 suggests broad bipartisan support for the underlying goal of expanding beneficiary autonomy in healthcare decisions. If enacted, the policy could shift how Medicare reimburses mobility equipment and potentially increase competition among suppliers, though the actual impact on device availability, quality, and program costs would depend on how the allowance amounts are set and what regulatory requirements apply to the alternative purchasing pathway.
Key provisions
- CMS must establish at least two Medicare billing codes for ultralightweight manual wheelchair bases: one for titanium/carbon fiber and one without.
- Suppliers receive the same Medicare payment for ultralightweight wheelchairs but may bill beneficiaries for the difference between payment and actual charge.
- CMS may require suppliers to inform Medicare beneficiaries of their potential financial liability when billing for wheelchair cost differences.
- The bill expands access to motorized mobility devices for Medicare beneficiaries by allowing cash allowance purchases as alternative to direct Medicare provision.
- The legislation increases beneficiary choice in mobility device selection, aiming to boost competition among suppliers and potentially lower costs.
More bills with recorded votes
Continue through the public record—each page includes the named roll call.
Spot an error? Tell us — corrections take priority.